International Liver Congress

Meeting News

Bezafibrate shows efficacy used in combination with UDCA for PBC

April 22, 2017
AMSTERDAM — Bezafibrate induced an additional biochemical response in patients with primary biliary cholangitis, improving pruritus and other…
Meeting News

Albumin treatment for cirrhosis improves overall survival

April 22, 2017
AMSTERDAM — Patients with cirrhosis who were treated with human albumin experienced improvement in a number of outcomes, including overall…
Meeting News

Sorafenib, selective internal radiation yield similar survival in HCC

April 22, 2017
AMSTERDAM — Selective internal radiation therapy failed to best Nexavar in overall survival but did yield improvements in other parameters…
Meeting NewsVideo

VIDEO: Viral decline, drug level measured with fine-needle aspiration

April 22, 2017
AMSTERDAM — In this exclusive video from International Liver Congress, Andrew Talal, MD, MPH, from the University of Buffalo, New…
Meeting News

Low-dose Sarasar combination therapies effective in treating HDV

April 22, 2017
AMSTERDAM — Lower doses of Sarasar, used in combination with ritonavir and pegylated interferon, effectively suppressed hepatitis delta virus…
Meeting News

Harvoni shows safety, efficacy in younger pediatric population

April 22, 2017
AMSTERDAM — A fixed, half-dose combination of Harvoni was associated with sustained virologic response rates of 99% or greater in a cohort of…
Meeting News

Generic therapies ‘overtook’ branded DAAs in 2016

April 22, 2017
AMSTERDAM — A presenter at today’s viral hepatitis session at the International Liver Congress called on the clinical community to push…
Meeting News

One-third of UK adolescents with HCV developed serious liver disease

April 21, 2017
AMSTERDAM — Approximately one-third of children under 18 years in the United Kingdom with hepatitis C developed serious long-term liver…
Meeting News

Zepatier yields high SVR12 in real-world VA cohort

April 21, 2017
AMSTERDAM — Zepatier was associated with SVR12 rates above 95% in a real-world, Veterans Affairs cohort, according to data presented at the…
Meeting News

CHECKMATE: Experienced HCC patients respond well to Opdivo

April 21, 2017
AMSTERDAM — Patients with HCC who failed prior therapy experienced encouraging survival outcomes and response rates with Opdivo, according to…